Balgopal Commercial Ltd. Shares of 19 Lakh Units Get Trading Approval from BSE
Balgopal Commercial Ltd. has received trading approval from the BSE Limited for a significant block of equity shares issued to its promoter. The company confirmed that 19,00,000 Equity Shares have been listed and are available for trading, effective from Wednesday, May 6, 2026.The shares relate to a preferential basis issuance made to a Promoter, stemming from the conversion of warrants.
According to the details confirmed by the company, the transaction involves the issuance of 19,00,000 Equity Shares of Balgopal Commercial Ltd. The face value of the shares is Rs. 10 each, and they were issued at a premium of Rs. 50 each.
The core transaction details are as follows:
| Parameter | Detail |
|---|---|
| Company | Balgopal Commercial Ltd. |
| Shares Issued | 19,00,000 Equity Shares |
| Face Value | Rs. 10 per share |
| Premium Paid | Rs. 50 per share |
| Basis of Issuance | Preferential basis (conversion of warrants) |
| Recipient | Promoter |
| Listing Effective Date | May 6, 2026 |
Stock Price Movement
As of 11:36, Balgopal Commercial Ltd shares are edging down, currently trading at ₹157.30, marking a significant 4.11% decline. The stock has traded within a wide intraday band, bouncing between a low of ₹157.05 and a high of ₹172.05.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.